These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2922053)

  • 61. Catalytic properties and immunoprecipitation of beta-glucuronidase in presence of its IgG and Fab fragments: identification of antigenic domains.
    Gupta GS; Singh G
    Indian J Biochem Biophys; 1988 Aug; 25(4):319-25. PubMed ID: 2467874
    [No Abstract]   [Full Text] [Related]  

  • 62. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The elicitation of carboxylesterase activity in antibodies by reactive immunization with labile organophosphorus antigens: a role for flexibility.
    Schowen RL
    J Immunol Methods; 2002 Nov; 269(1-2):59-65. PubMed ID: 12379352
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of the hydrolytic activity of a polyclonal catalytic antibody preparation by pH-dependence and chemical modification studies: evidence for the involvement of Tyr and Arg side chains as hydrogen-bond donors.
    Resmini M; Vigna R; Simms C; Barber NJ; Hagi-Pavli EP; Watts AB; Verma C; Gallacher G; Brocklehurst K
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):279-87. PubMed ID: 9337880
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Natural catalytic antibodies.
    Paul S
    Mol Biotechnol; 1996 Jun; 5(3):197-207. PubMed ID: 8837026
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection strategies for catalytic antibodies.
    Reymond JL
    J Immunol Methods; 2002 Nov; 269(1-2):125-31. PubMed ID: 12379357
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibody catalyzed cationic cyclization.
    Li T; Janda KD; Ashley JA; Lerner RA
    Science; 1994 May; 264(5163):1289-93. PubMed ID: 8191282
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sequence-specific peptide cleavage catalyzed by an antibody.
    Iverson BL; Lerner RA
    Science; 1989 Mar; 243(4895):1184-8. PubMed ID: 2922606
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibody catalysis of peptide bond formation.
    Jacobsen JR; Schultz PG
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5888-92. PubMed ID: 8016084
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Catalytic antibodies.
    Tramontano A; Janda KD; Lerner RA
    Science; 1986 Dec; 234(4783):1566-70. PubMed ID: 3787261
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polyclonal antibodies and catalysis.
    Stephens DB; Wilmore BH; Iverson BL
    Bioorg Med Chem; 1994 Jul; 2(7):653-8. PubMed ID: 7858972
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Catalytic antibodies].
    Baron D
    Naturwissenschaften; 1992 Jan; 79(1):15-22. PubMed ID: 1552949
    [TBL] [Abstract][Full Text] [Related]  

  • 73. pH dependence of antibody: hapten association.
    Livesay D; Linthicum S; Subramaniam S
    Mol Immunol; 1999 Apr; 36(6):397-410. PubMed ID: 10444003
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design of the hapten for the induction of antibodies catalyzing aldol reaction.
    Teraishi K; Saito M; Fujii I; Nakamura H
    J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Computer modeling of combining site structure of anti-hapten monoclonal antibodies.
    Bolger MB; Sherman MA
    Methods Enzymol; 1991; 203():21-45. PubMed ID: 1762557
    [No Abstract]   [Full Text] [Related]  

  • 76. Selective chemical catalysis by an antibody.
    Pollack SJ; Jacobs JW; Schultz PG
    Science; 1986 Dec; 234(4783):1570-3. PubMed ID: 3787262
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of cleaving interchain disulfide bridges on the radius of gyration and maximum length of anti-poly(D-alanyl) antibodies before and after reaction with tetraalanine hapten.
    Pilz I; Schwarz E; Durchschein W; Light A; Sela M
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):117-21. PubMed ID: 6767235
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Principles for designing enzyme-like catalysts based on the rate-acceleration mechanisms of semisynthetic oxidases.
    Yomo T; Urabe I; Okada H
    Eur J Biochem; 1992 Feb; 203(3):543-50. PubMed ID: 1735438
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Blue-fluorescent antibodies.
    Simeonov A; Matsushita M; Juban EA; Thompson EH; Hoffman TZ; Beuscher AE; Taylor MJ; Wirsching P; Rettig W; McCusker JK; Stevens RC; Millar DP; Schultz PG; Lerner RA; Janda KD
    Science; 2000 Oct; 290(5490):307-13. PubMed ID: 11030644
    [TBL] [Abstract][Full Text] [Related]  

  • 80. pH on-off switching of antibody-hapten binding by site-specific chemical modification of tyrosine.
    Tawfik DS; Chap R; Eshhar Z; Green BS
    Protein Eng; 1994 Mar; 7(3):431-4. PubMed ID: 8177892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.